Here are five key notes:
1. Bioventus’ board of managers appointed Mr. Hawkins chairman. He is replacing Dan Lemaitre, who served as chairman since 2012 and recently decided to leave the company’s board.
2. Mr. Hawkins has experience as president and CEO of Immucor, a transfusion and transplantation device company. He has experience in leadership roles at Johnson & Johnson and Eli Lilly and Company in addition to his experience at Medtronic.
3. During his time with Medtronic, Mr. Hawkins built a strong background in orthobiologics including BMP products, which will be beneficial for Bioventus going forward.
4. Mr. Hawkins earned his MBA from Dardan School of Business at the University of Virginia.
5. Throughout his career, Mr. Hawkins has served on private and public, for-profit and non-profit boards. He has been on the board of directors for AdvaMed, Minneapolis Institute of Arts and University of Minnesota Foundation.
More articles on orthopedic devices:
Orthopedic power tools industry report 2016—6 quick notes
21 spine devices receive FDA 510(k) clearance in December
K2M 2015 preliminary revenue up 16%: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
